451
Views
1
CrossRef citations to date
0
Altmetric
ENDOMETRIOSIS

A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms

, , &
Pages 403-406 | Received 24 Jan 2022, Accepted 13 Mar 2022, Published online: 23 Mar 2022

References

  • Johnson NP, Hummelshoj L, Abrao MS, et al. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–1568.
  • Almasi MZ, Hosseini E, Jafari R, et al. Evaluation of toll-like receptor 3 (TLR3) signaling pathway genes and its genetic polymorphisms in ectopic and eutopic endometrium of women with endometriosis. J Gynecol Obstet Hum Reprod. 2021; 50(9):102153.
  • Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256.
  • Kaponis A, Taniguchi F, Azuma Y, et al. Current treatment of endometrioma. Obstet Gynecol Surv. 2015;70(3):183–195.
  • Bulun SE. Endometriosis. N Engl J Med. 2009; 360(3):268–279.
  • Becker CM, Gattrell WT, Gude K, et al. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017; 108(1):125–136.
  • Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018; 131(3):557–571.
  • Marinho MCP, Magalhaes TF, Fernandes LFC, et al. Quality of life in women with endometriosis: an integrative review. J Womens Health (Larchmt). 2018;27(3):399–408.
  • Keller SD, Bayliss MS, Ware JE, et al. Comparison of responses to SF-36 health survey questions with one-week and four-week recall periods. Health Serv Res. 1997;32(3):367–384.
  • Thong ISK, Jensen MP, Miró J, et al. The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain. 2018;18(1):99–107.
  • Maggiore ULR, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol. 2017;209:81–85.
  • Busacca M, Marana R, Caruana P, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Am J Obstet Gynecol. 1999;180(Pt 1):519–523.
  • Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20(10):2698–2704.
  • Köhler G, Faustmann TA, Gerlinger C, et al. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. Int J Gynecol Obstet. 2010; 108(1):21–25.
  • Sugimoto K, Nagata C, Hayashi H, et al. Use of dienogest over 53 weeks for the treatment of endometriosis. J Obstet Gynaecol Res. 2015;41(12):1921–1926.
  • Mueck AO. Dienogest: an oral progestogen for the treatment of endometriosis. Expert Rev Obstet Gynecol. 2011;6(1):5–15.
  • Römer T. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet. 2018;298(4):747–753.
  • Momoeda M, Harada T, Terakawa N, et al. Long-term use of dienogest for the treatment of endometriosis . J Obstet Gynaecol Res. 2009; 35(6):1069–1076.
  • Strowitzki T, Faustmann T, Gerlinger C, et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2010;151(2):193–198.
  • Karacan T, Kiyak H, Ozyurek E, et al. Comparison of the efficacy and tolerability of dienogest and dienogest plus ethinylestradiol on endometriosis related-pain. Gynecol Obstet Reprod Med. 2020;26(3):192–198.
  • Vignali M, Belloni GM, Pietropaolo G, et al. Effect of dienogest therapy on the size of the endometrioma. Gynecol Endocrinol. 2020;36(8):723–727.
  • Xholli A, Filip G, Previtera F, et al. Modification of endometrioma size during hormone therapy containing dienogest. Gynecol Endocrinol. 2020;36(6):545–549.
  • Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36(1):84–86.
  • Agarwal SK, Foster WG. Reduction in endometrioma size with three months of aromatase inhibition and progestin add-back. Biomed Res Int. 2015;2015:878517.
  • Barra F, Grandi G, Tantari M, et al. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opin Biol Ther. 2019; 19(4):343–360.
  • Lee SR, Yi KW, Song JY, et al. Efficacy and safety of long-term use of dienogest in women with ovarian endometrioma. Reprod Sci. 2018; 25(3):341–346.
  • Lövkvist L, Boström P, Edlund M, et al. Age-related differences in quality of life in Swedish women with endometriosis. J Women’s Health. 2016;25(6):646–653.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.